Initial concerns were raised after findings from the cardiovascular outcome trial (CVOT), Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes 6 (SUSTAIN 6), revealed a greater risk of DR-related complications, defined as the need for laser therapy, intravitreal injections, development of vitreous hemorrhage, and blindness, in semaglutide users compared to placebo (3.0% vs 1.8%, HR=1.76, P =.02)
2020JH2/10300050) to this article
When fat is removed through weight loss, it becomes overstretched and unable to snap back to its original form
offered an improved perspective for the long-term cost-effectiveness of GLP-1 RAs by showcasing benefits in QALYs and reduced lifetime healthcare costs [81]
Talk with a licensed provider before starting or changing any prescription treatment
Theres no need to mix powders, measure doses with syringes or find sterile conditions for injection